Ticker: AXSM

Axsome Therapeutics, Inc. (NASDAQ: AXSM) continues to manage a challenging financial landscape while striving to expand its portfolio of central nervous system therapies. As of June 30, 2025, the company reported notable achievements in its income statement alongside areas of concern. Key Financi...